Challenges and future perspectives for minimal residual disease (MRD) in multiple myeloma
Bruno Paiva et al.
The important issues to consider when deciding when a multiple myeloma patient must start treatment
The use of immunotherapies in combination for the treatment of multiple myeloma
Heinz Ludwig et al.